Skip to main content

FDA expected to approve esketamine nasal spray for depression

By NPR  
   March 05, 2019

The Food and Drug Administration is expected to approve a new type of drug for depression. It is esketamine, a chemical cousin of the anesthetic and party drug ketamine.

Full story

Tagged Under:


Get the latest on healthcare leadership in your inbox.